Investigation of antidepressant-like and anxiolytic-like actions and cognitive and motor side effects of four N-methyl-d-aspartate receptor antagonists in mice
Authors:
- Darryl S. PickeringDPDarryl S. Pickering
- Jesper T. AndreasenJAJesper T. Andreasen
- 1 February 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Behavioural Pharmacology
- Vol. 28 (1) , 37-47
Abstract
Evidence suggests thatN-methyl-d-aspartate receptor (NMDAR) antagonists could be efficacious in treating depression and anxiety, but side effects constitute a challenge. This study evaluated the antidepressant-like and anxiolytic-like actions, and cognitive and motor side effects of four NMDAR antagonists. MK-801, ketamine,S-ketamine, RO 25-6981 and the positive control, citalopram, were tested for antidepressant-like and anxiolytic-like effects in mice using the forced-swim test, the elevated zero maze and the novelty-induced hypophagia test. Side effects were assessed using a locomotor activity test, the modified Y-maze and the rotarod test. All compounds increased swim distance in the forced-swim test. In the elevated zero maze, the GluN2B subtype-selective RO 25-6981 affected none of the measured parameters, whereas all other compounds showed anxiolytic-like effects. In the novelty-induced hypophagia test, citalopram and MK-801 showed anxiogenic-like action. All NMDAR antagonists induced hyperactivity. The high doses of ketamine and MK-801 impaired performance in the modified Y-maze test, whereasS-ketamine and RO 25-6891 showed no effects in this test. Only MK-801 impaired rotarod performance. The study supports that NMDARs could be a possible therapeutic target for treating depression and anxiety. However, selective antagonism of GluN2B subunit-containing NMDARs showed no effect on anxiety-like behaviours in this study.Keywords
This publication has 77 references indexed in Scilit:
- Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic actionBrain Research, 2015
- Does increasing the ratio of AMPA-to-NMDA receptor mediated neurotransmission engender antidepressant action? Studies in the mouse forced swim and tail suspension testsNeuroscience Letters, 2013
- Chronic intermittent ethanol and withdrawal differentially modulate basolateral amygdala AMPA-type glutamate receptor function and traffickingNeuropharmacology, 2012
- Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levelsNeurochemistry International, 2011
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responsesNature, 2011
- Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim testJournal of Psychopharmacology, 2010
- In vitro and in vivo studies in rats with LY293558 suggest AMPA/kainate receptor blockade as a novel potential mechanism for the therapeutic treatment of anxiety disordersPsychopharmacology, 2006
- Ketamine-induced changes in rat behaviour: A possible animal model of schizophreniaProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2003
- Antidepressant effects of ketamine in depressed patientsBiological Psychiatry, 2000
- Restoration of shock‐suppressed behavior by treatment with (+)‐5‐methyl‐10,11‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5, 10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic propertiesDrug Development Research, 1982